Impact of preoperative chemotherapy on perioperative morbidity in combined resection of colon cancer and liver metastases

ConclusionPatients who are deemed to be candidates for preoperative chemotherapy can proceed with planned neoadjuvant chemotherapy prior to combined resection of primary colon cancer and sLM as preoperative neoadjuvant chemotherapy does not appear to be associated with increased postoperative morbidity.
Source: Journal of Gastrointestinal Surgery - Category: Surgery Source Type: research